The B2B Podcast Index
Index
All categories
MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
MethodologySubmit
Best of:MarketingSalesSaaSFinanceHROpsLeadershipCustomer SuccessAI & DataProductStartups & FoundersRevOpsEngineering & DevTools
An independent project byFame
SearchBest episodesGuestsInsightsMethodologySubmit a podcast
Index/HR/CLEARly Beneficial Podcast
CLEARly Beneficial Podcast artwork

[S2E11] Joey Dizenhouse: Follow the Money: Inside the Pharmacy Supply Chain

CLEARly Beneficial Podcast · 2026-03-24 · 43 min

0:00--:--

Topics in this episode

GLP-1 medicationsdrug pricingpharmacy benefitsPBM transparencypharmacy spend

Episode notes

How PBMs, Rebates, and Drug Pricing Are Draining Your Benefits Budget Pharmacy costs have ballooned from 12% of the healthcare dollar in 2000 to 30 - 50% today - and most employers have no idea why or what to do about it. Joey Dizenhouse, CEO of SlateRx and a 25-year actuary and benefits veteran, pulls back the curtain on the systems, incentives, and hidden money flows that make pharmacy one of the most complex - and costly - benefits to manage. In this episode, Joey and Vincent dig into the five levers every plan sponsor needs to understand: unit cost, utilization, mix, volatility, and engagement. From the GLP-1 tidal wave and next-generation weight loss drugs to the 19 different forms of “rebate” money that may never reach your plan, Joey explains why sound-bite solutions fall short and what it actually takes to build a smarter pharmacy program. Joey also tackles the uncomfortable truth about advisor and PBM conflicts of interest - and why asking the right questions may be the single most important thing a plan sponsor can do to protect their fiduciary standing and their people.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

  • Stop Paying. Start Leading: Taking Control of Healthcare Strategy (Feat: Paul Dumas)Broken Benefits · on GLP-1 medications95 / 100
  • The State of Managed Care: What Health Plans Must Get Right in 2026Soaring to New Health · on GLP-1 medications86 / 100
  • Cash Pay From the Pharma Manufacturer Point of View, With Ophelia JohnsonRelentless Health Value · on GLP-1 medications86 / 100
  • #288 Why Great Companies Lose Their Way After Going Public with Eric Ries Author The Lean StartupGrowCFO Show · on GLP-1 medications84 / 100
  • Episode #113: Brian Underwood, Beauty & Grooming Director, Men’s Health and Women’s HealthHospitality Forward · on GLP-1 medications76 / 100
  • The weight-loss era is not just about selling clothesThe Backroom with Retail Dive · on GLP-1 medications71 / 100

More from CLEARly Beneficial Podcast

All episodes →
  • [S2E24] The Kaiser/Non-Kaiser Death Spiral: What Employers Need to Know61 / 100
  • [S2E22] HR & CFO’s: Before Benefits Decision Season Begins, Start Here.52 / 100
  • [S2E21] From Cannes: The Rest of the World Posts the Price. America Won't.39 / 100
  • [S2E20] Vincent Catalano: Let’s Not Normalize Medical Debt49 / 100
  • [S2E19] Healthcare Big Ideas86 / 100
Explore the best B2B HR podcasts →
All CLEARly Beneficial Podcast episodes →